Clinical Trials Sponsored by Hospital Ana Nery

Total 13086 results

HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI); Transfusion Medicine/Hemostasis...

Completed

Optimal Platelet Dose Strategy for Management of Thrombocytopenia (PLADO)

Thrombocytopenia

United States
HealthCore-NERI
National Institute on Minority Health and Health Disparities (NIMHD); Orange...

Completed

Fourth Trimester - A Web-based Tool for Postpartum Care to Address the Needs of Underserved Women

Pregnancy Related | Postpartum Sadness

United States
San Filippo Neri General Hospital
MENDES S.A., Lugano, Switzerland; Università degli studi di Bologna, Italy

Unknown

MYocardial DAmage AND MIcrobiota STUDY (MYDA-MI)

Chronic Stable Angina | Periprocedural Myocardial Damage

Italy
Azienda Ospedaliero, Universitaria Pisana
San Filippo Neri General Hospital; Hospital San Jacopo; Azienda Sanitaria Universitaria...

Unknown

Comparision Among Classifications for Acute Diverticulitis: a Multicenter Study

Acute Diverticulitis

Italy
HealthCore-NERI
National Heart, Lung, and Blood Institute (NHLBI); FDA Office of Orphan Products... and other collaborators

Completed

Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome--Pediatric Heart Network

Marfan Syndrome

United States, Canada, Belgium
Sungsoo Park
Chung-Ang University Hosptial, Chung-Ang University College of Medicine; Kosin...

Unknown

Comparison of Treatment Outcome and Cost-effectiveness for GERD

Gastroesophageal Reflux

Korea, Republic of
Ana Jordan

Recruiting

Biomarkers in Pulsed Field Ablation Versus Cryoballoon Ablation

Atrial Fibrillation

Croatia
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate

Malignant Pleural Mesothelioma | Pleural Mesothelioma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer

NSCLC | Lung Cancer | Non-small Cell Lung Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate

Malignant Pleural Mesothelioma | Pleural Mesothelioma

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy

Hodgkin's Disease

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation

Multiple Myeloma | Hodgkin's Lymphoma | AML | Hematologic Malignancy | NHL | CML | ALL

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia

Acute Myelogenous Leukemia | Myelodysplasia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer

Malignant Tumors | Subcutaneous Tumors | Lymph Node Tumors

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

Heart Failure

United States, Canada
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cancer

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor

Glioma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer

Pancreatic Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer

Early-Stage Breast Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma

Stomach Cancer | Gastric Cancer | Gastro-esophageal Junction Cancer

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer

Prostate Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer

Breast Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies

Solid Tumor

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Brigham and Women's Hospital
Dana-Farber Cancer Institute

Not yet recruiting

Early Neutropenic Fever De-escalation of Antibiotics Study (END)

Febrile Neutropenia | Hematologic Malignancy | Antibiotic Stewardship
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Active, not recruiting

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

Gynecologic Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Active, not recruiting

Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation

Hodgkin's Disease

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding

Prostate Cancer
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Vaccination With Autologous Breast Cancer Cells Engineered to Secrete Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Metastatic Breast Cancer Patients

Breast Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies

Refractory Acute Myeloid Leukemia | Myelodysplastic Syndrome RAEB-I or RAEB-II | Refractory CML Myeloid Blast Crisis

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination

Chronic Lymphocytic Leukemia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Chronic Lymphocytic Leukemia

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease

Lung Cancer

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease

Graft vs Host Disease

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Terminated

Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Hematologic Malignancies | Hodgkin's Disease | Myelogenous Leukemia

United States
Brigham and Women's Hospital
Dana-Farber Cancer Institute

Terminated

UVB Phototherapy Treatment of Oral Chronic GVHD

Oral Chronic Graft-Versus-Host Disease

United States
Dana-Farber Cancer Institute
Brigham and Women's Hospital

Completed

Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma

Cervix Cancer | Endometrial Carcinoma | Carcinoma of the Uterus

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Active, not recruiting

Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)

Melanoma

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin

Ovarian Carcinoma
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies

Solid Tumor

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Terminated

Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | Mixed Tumor, Mesodermal

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

Cervical Cancer | Breast Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal Cancer

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Terminated

Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

Pancreatic Cancer

United States
Dana-Farber Cancer Institute
Boston Children's Hospital; Brigham and Women's Hospital

Completed

Study of Iressa in Patients With Relapsed or Refractory Acute Myelogenous Leukemia

Myelogenous Leukemia, Acute

United States
Massachusetts General Hospital
Dana-Farber Cancer Institute; Brigham and Women's Hospital

Completed

Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

Ovarian Cancer | Peritoneal Carcinoma | Tubal Carcinoma

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus

Adenocarcinoma of Stomach | Adenocarcinoma of GE Junction | Adenocarcinoma of Esophagus

United States
Dana-Farber Cancer Institute
Massachusetts General Hospital; Brigham and Women's Hospital

Completed

Bevacizumab and Carboplatin/Paclitaxel and Radiation in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States

Clinical Trials Sponsored by Hospital Ana Nery

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Colombia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations